Expression of keratinocyte growth factor receptor (KGFR/FGFR2 IIIb) in vascular smooth muscle cells

Pathology International

Volumn 53, Issue 3, 2003, Pages 127-132

  Onda, Munehiko ^a,b   Naito, Zenya ^a   Wang, Ruojiao ^a   Fujii, Takenori ^a   Kawahara, Kiyoko ^a   Ishiwata, Toshiyuki ^a   Sugisaki, Yuichi ^a  

^a NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Atherosclerosis; Coronary artery; FGF 10; Fibroblast growth factor (FGF) 7; Keratinocyte growth factor receptor (KGFR FGFR2 IIIb); Vascular smooth muscle cells

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 2; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR; MESSENGER RNA; RECOMBINANT FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; MESENCHYME CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANIMALS; ATHEROSCLEROSIS; CELL SURVIVAL; CELLS, CULTURED; CORONARY VESSELS; DRUG COMBINATIONS; FEMALE; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, WISTAR; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 0037356126     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2003.01445.x     Document Type: Article

References (43)

1. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001; 2: 1-12.
2. Mason IJ. The ins and outs of fibroblast growth factor. Cell 1994; 78: 547-52.
3. Kornmann M, Beger HG, Korc M. Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. Pancreas 1998; 17: 169-75.
4. Ishiwata T, Friess H, Buchler MW, Lopez ME, Korc M. Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol 1998; 153: 213-22.
5. Ishiwata T, Kornmann M, Beget HG, Korc M. Enhanced fibroblast growth factor 5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitis. Gut 1998; 43: 134-9.
6. Kornmann M, Ishiwata T, Beger HG, Korc M. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene 1997; 15: 1417-24.
7. Givol D, Yayon A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 1992; 6: 3362-9.
8. Ornitz DM, Xu J, Colvin JS et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996; 271: 15 292-7.
9. Fernig DG, Gallagher JT. Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 1994; 5: 353-77.
10. Friesel RE, Maciag T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 1995; 9: 919-25.
11. Johnson DE, Williams LT. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993; 60: 1-41.
12. Avivi A, Yayon A, Givol D. A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III. FASEB Lett 1993; 330: 249-52.
13. Kornmann M, Ishiwata T, Matsuda K et al. IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells. Gastroenterology 2002; 123: 301-13.
14. Gilbert E, Del Gatto F, Champion-Arnaud P, Gesnel M-C, Breathnach R. Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA. Mol Cell Biol 1993; 13: 5461-8.
15. Orr-Urtreger A, BedfordMT, Burakova T et al. Developmental localization of the splicing alternatives of the fibroblast growth factor receptor-2 (FGFR-2). Dev Biol 1993; 158: 475-86.
16. Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 1993; 13: 4513-22.
17. Alarid ET, Rubin JS, Young P et al. Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 1994; 91: 1074-8.
18. Miki T, Fleming TP, Bottaro DP, Rubin JS, Ron D, Aaronson SA. Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 1991; 251: 72-5.
19. Miki T, Bottaro DP, Fleming TP et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 1992; 89: 246-50.
20. Igarashi M, Finch PW, Aaronson SA. Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarity with keratinocyte growth factor (FGF)-7. J Biol Chem 1998; 273: 13 230-35.
21. Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai P. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci USA 1998; 95: 5082-7.
22. De Moerlooze L, Spencer-Dene B, Revest J-M, Hajihosseini M, Rosewell L, Dickson C. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 2000; 127: 483-92.
23. Xu X, Weinstein M, Li C et al. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 1998; 125: 753-65.
24. Revest J-M, Spencer-Dene B, Kerr K, De Moerlooze L, Rosewell I, Dickson C. Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev Biol 2001; 231: 47-62.
25. Raines EW. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationship to vascular disease. Int J Exp Path 2000; 81: 173-82.
26. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991; 253: 1129-32.
27. Cuevas P, Gonzalez AM, Carceller F, Baird A. Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery. Circ Res 1991; 69: 360-69.
28. Miyagawa J, Higashiyama S, Kawata S et al. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J Clin Invest 1995; 95: 404-11.
29. Mitsumata M, Gamou S, Shimizu N, Yoshida Y. Response of atherosclerotic intimal smooth muscle cells to epidermal growth factor in vitro. Arterioscler Thromb 1994; 14: 1364-71.
30. Ferns GA, Motani AS, Anggard EE. The insulin-like growth factors: their putative role in atherogenesis. Artery 1991; 18: 197-225.
31. Winkles JA, Alberts GF, Chedid M, Taylor WG, DeMartino S, Rubin JS. Differential expression of the keratinocyte growth factor (KGF) and KGF receptor genes in human vascular smooth muscle cells and arteries. J Cell Physiol 1997; 173: 380-86.
32. Qin H, Ishiwata T, Asano G. Effects of the extracellular matrix on lumican expression in rat aortic smooth muscle cells in vitro. J Pathol 2001; 195: 604-8.
33. Wang R, Kudo M, Yokoyama M, Asano G. Roles of advanced endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth. J Nippon Med Sch 2001; 68: 472-81.
34. Ishiwata T, Naito Z, Lu YP et al. Differential distribution of fibroblast growth factor (FGF)-7 and FGF-10 in 1-arginine-induced acute pancreatitis. Exp Mol Pathol 2002; 73: 181-90.
35. Study Group on the Classification of Atherosclerotic Lesions. Classification of Atherosclerotic Lesions-Report of a Study Group. World Health Organization Technical Report Series 143 Geneva: World Health Organization, 1958.
36. Onda M, Ishiwata T, Kawahara K, Wang R, Naito Z, Sugisaki Y. Expression of lumican in thickened intima and smooth muscle cells in human coronary atherosclerosis. Exp Mol Pathol 2002; 72: 142-9.
37. Johnson DE, Lu J, Chen H, Werner S, Williams LT. The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 1991; 11: 4627-34.
38. Burke D, Wilkes D, Blundell TL, Malcolm S. Fibroblast growth factor receptors: lessons from the genes. Trens Biochem Sci 1998; 23: 59-62.
39. Galzie Z, Kinsella AR, Smith JA. Fibroblast growth factors and their receptors. Biochem Cell Biol 1997; 75: 669-85.
40. Jameson J, Ugarte K, Chen N, Yachi P et al. A role for skin gammadelta T cells in wound repair. Science 2002; 296: 747-9.
41. Marchese C, Felici A, Visco V et al. Fibroblast growth factor 10 induces proliferation and differentiation of human primary cultured keratinocytes. J Invest Dermatol 2001; 116: 623-8.
42. Ohuchi H, Hori Y, Yamasaki M et al. FGF 10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun 2000; 277: 643-9.
43. Savagner P, Valles AM, Jouanneau J, Yamada KM, Thiery JP. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell 1994; 5: 851-62.